All In MedTech

Device Trial Radar · NCT07651852

Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation

Last checked: Nov 20, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

500

Planned (sponsor's estimate)

Start

Oct 9, 2026

Primary completion

Oct 2029

Study completion Oct 2029

Sponsor

Lead sponsor
Kardium Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 16, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This post-market registry is designed to collect real world data on the use of the Globe PF System for the treatment of atrial fibrillation (AF).

Conditions

  • Atrial Fibrillation

Interventions

  • Globe Pulsed Field SystemDevice

    Ablation and atrial mapping with the Globe Pulsed Field System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Effectiveness endpointTime frame: 12 months
  2. Safety endpointTime frame: 7 days

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Arrhythmia Research Group

    Jonesboro, Arkansas · Recruiting

  • Overlake Hospital

    Bellevue, Washington · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.